Subscribe To
SVRA / Why Shares of Savara Jumped on Tuesday
SVRA News
By Seeking Alpha
July 16, 2023
Savara: A Speculative Play
Today, we circle back on a small development firm called Savara for the first time in over two years. Its primary drug candidate is being developed fo more_horizontal
By Business Wire
June 2, 2023
Savara to Present at the Jefferies Healthcare Conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ann more_horizontal
By The Motley Fool
May 16, 2023
Why Shares of Savara Jumped on Tuesday
Savara is a clinical-stage pharmaceutical company with no revenue. The company expects a top-line readout on molgramostim in the second quarter of 202 more_horizontal
By Business Wire
March 6, 2023
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference
AUSTIN, Texas--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today ann more_horizontal
By The Motley Fool
January 27, 2023
Why Shares of Savara Soared This Week
The clinical-stage biopharmaceutical company focuses on therapies to treat rare respiratory diseases. more_horizontal